152 related articles for article (PubMed ID: 20980741)
41. [Rationale and clinical evidence for the use of rituximab in glomerular diseases].
Mani LY; Vogt B; Burnier M; Golshayan D
Rev Med Suisse; 2011 Apr; 7(290):819-24. PubMed ID: 21595313
[TBL] [Abstract][Full Text] [Related]
42. Otosyphilis mimics immune disorders of the inner ear.
García-Berrocal JR; Górriz C; Ramírez-Camacho R; Trinidad A; Ibáñez A; Rodríguez Valiente A; González JA
Acta Otolaryngol; 2006 Jul; 126(7):679-84. PubMed ID: 16803704
[TBL] [Abstract][Full Text] [Related]
43. [Vibrant Sound Bridge System. A new kind hearing prosthesis for patients with sensorineural hearing loss. 2. Audiological results].
Lenarz T; Weber BP; Issing PR; Gnadeberg D; Ambjørnsen K; Mack KF; Winter M
Laryngorhinootologie; 2001 Jul; 80(7):370-80. PubMed ID: 11488147
[TBL] [Abstract][Full Text] [Related]
44. Conductive hearing loss: investigation of possible inner ear origin in three cases studies.
Al Muhaimeed H; El Sayed Y; Rabah A; Al-Essa A
J Laryngol Otol; 2002 Nov; 116(11):942-5. PubMed ID: 12487675
[TBL] [Abstract][Full Text] [Related]
45. [Progressive inner ear diseases--sequelae of a secondary autoimmune process? Significance of antibodies to endoplasmic reticulum].
Zanetti F; Klein R; Berg PA
HNO; 1987 Jan; 35(1):34-7. PubMed ID: 3549636
[TBL] [Abstract][Full Text] [Related]
46. Autoimmune inner ear disease: steroid and cytotoxic drug therapy.
Lasak JM; Sataloff RT; Hawkshaw M; Carey TE; Lyons KM; Spiegel JR
Ear Nose Throat J; 2001 Nov; 80(11):808-11, 815-6, 818 passim. PubMed ID: 11816893
[TBL] [Abstract][Full Text] [Related]
47. [The role of plasmapheresis in the treatment of patients with sensorineural deafness].
Sichkareva TA; Vishniakov VV; Kutepov DE
Vestn Otorinolaringol; 2009; (3):36-8. PubMed ID: 19692965
[TBL] [Abstract][Full Text] [Related]
48. Intratympanic methylprednisolone for sudden sensorineural hearing loss.
Kiliç R; Safak MA; Oğuz H; Kargin S; Demirci M; Samim E; Ozlüoğlu LN
Otol Neurotol; 2007 Apr; 28(3):312-6. PubMed ID: 17414035
[TBL] [Abstract][Full Text] [Related]
49. Otologics middle ear transducer with contralateral conventional hearing aid in severe sensorineural hearing loss: evolution during the first 24 months.
Tringali S; Perrot X; Berger P; Granade GL; Dubreuil C; Truy E
Otol Neurotol; 2010 Jun; 31(4):630-6. PubMed ID: 20418795
[TBL] [Abstract][Full Text] [Related]
50. [Autoimmune disease of the inner ear].
Cinco Balderas E; Paquot Chico RO; López Ríos G; Kim ML
Gac Med Mex; 1992; 128(3):271-4. PubMed ID: 1302729
[No Abstract] [Full Text] [Related]
51. Rituximab for severe myasthenia gravis--experience from five patients.
Lindberg C; Bokarewa M
Acta Neurol Scand; 2010 Oct; 122(4):225-8. PubMed ID: 20199513
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
Seo P; Specks U; Keogh KA
J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
[TBL] [Abstract][Full Text] [Related]
53. Practical versus theoretical management of autoimmune inner ear disease.
Hughes GB; Kinney SE; Barna BP; Calabrese LH
Laryngoscope; 1984 Jun; 94(6):758-67. PubMed ID: 6374341
[TBL] [Abstract][Full Text] [Related]
54. Rituximab therapy for autoimmune haematological diseases.
Barcellini W; Zanella A
Eur J Intern Med; 2011 Jun; 22(3):220-9. PubMed ID: 21570637
[TBL] [Abstract][Full Text] [Related]
55. Immune-Mediated Inner Ear Disease: Diagnostic and therapeutic approaches.
Penêda JF; Lima NB; Monteiro F; Silva JV; Gama R; Condé A
Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(2):97-104. PubMed ID: 29525415
[TBL] [Abstract][Full Text] [Related]
56. High dose combination pertussis toxin induces autoimmune inner ear disease in Sprague-Dawley rats.
Kong WJ; Wang DY; Huang X; Ding GF
Acta Otolaryngol; 2011 Jul; 131(7):692-700. PubMed ID: 21366505
[TBL] [Abstract][Full Text] [Related]
57. Fundamental immune mechanisms of the brain and inner ear.
Harris JP; Ryan AF
Otolaryngol Head Neck Surg; 1995 Jun; 112(6):639-53. PubMed ID: 7777346
[TBL] [Abstract][Full Text] [Related]
58. Sensorineural hearing loss in linear IgA disease.
Tasca RA; Hanif J; Glover GW
Auris Nasus Larynx; 2003 Aug; 30(3):291-3. PubMed ID: 12927295
[TBL] [Abstract][Full Text] [Related]
59. Cochlin in autoimmune inner ear disease: is the search for an inner ear autoantigen over?
Baruah P
Auris Nasus Larynx; 2014 Dec; 41(6):499-501. PubMed ID: 25199741
[TBL] [Abstract][Full Text] [Related]
60. Immunosuppressive therapy for autoimmune inner ear disease.
Buniel MC; Geelan-Hansen K; Weber PC; Tuohy VK
Immunotherapy; 2009 May; 1(3):425-34. PubMed ID: 19885385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
